Cyp2c54 inhibitors are a specialized class of chemical compounds designed to selectively target and inhibit the activity of the Cyp2c54 enzyme, which is a member of the cytochrome P450 superfamily. The Cyp2c54 enzyme is involved in the oxidative metabolism of a variety of substrates, including endogenous molecules such as fatty acids, steroids, and other lipophilic compounds, as well as exogenous substances like drugs and environmental toxins. This enzyme catalyzes the monooxygenation of its substrates, a crucial biochemical process that introduces an oxygen atom into the substrate. This oxidative reaction often enhances the solubility of the substrate, facilitating its further metabolism or excretion from the body. Cyp2c54's activity is particularly important in tissues like the liver, where it plays a significant role in the metabolism and detoxification processes that are essential for maintaining homeostasis and protecting the organism from harmful substances.
Inhibitors of Cyp2c54 are typically small molecules designed to bind specifically to the active site of the enzyme, blocking its ability to interact with and oxidize its natural substrates. These inhibitors may function by occupying the substrate-binding pocket, thereby preventing the enzyme from catalyzing the oxidation process, or by inducing conformational changes that reduce the enzyme's catalytic efficiency. The development of Cyp2c54 inhibitors requires a thorough understanding of the enzyme's three-dimensional structure, particularly the regions involved in substrate recognition and catalysis. By inhibiting Cyp2c54, researchers can explore the enzyme's specific role in various metabolic pathways and assess how its inhibition affects the broader network of cytochrome P450-mediated reactions. The study of Cyp2c54 inhibitors provides valuable insights into the enzyme's substrate specificity, its interactions with other metabolic enzymes, and its overall contribution to the maintenance of metabolic balance within the body. This research enhances our understanding of the diverse functions of cytochrome P450 enzymes, emphasizing their critical roles in the biotransformation and detoxification processes that are vital for cellular and systemic health.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Nonsteroidal anti-inflammatory drug (NSAID) inhibiting CYP2C54 by suppressing arachidonic acid metabolic processes. Alters membrane dynamics, reducing substrate availability for the enzyme. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Class I antiarrhythmic drug indirectly inhibiting CYP2C54 by modulating intracellular calcium levels. Alters membrane-bounded organelle functions, affecting the enzyme's predicted location. | ||||||
Ticlopidine Hydrochloride | 53885-35-1 | sc-205861 sc-205861A | 1 g 5 g | $32.00 $99.00 | 2 | |
Antiplatelet agent inhibiting CYP2C54 indirectly through interference with linoleic acid metabolic processes. Disrupts intracellular membrane functions, impacting the enzyme's activity. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Antifungal agent in research acting as a direct inhibitor of CYP2C54 by binding to its active site. Alters endoplasmic reticulum dynamics, hindering the enzyme's participation in arachidonic acid metabolism. | ||||||
Triclosan | 3380-34-5 | sc-220326 sc-220326A | 10 g 100 g | $141.00 $408.00 | ||
Broad-spectrum antimicrobial indirectly inhibiting CYP2C54 by disrupting membrane integrity. Influences cytoplasmic and intracellular membrane functions, impacting the enzyme's predicted activity. | ||||||
Diclofenac Sodium | 15307-79-6 | sc-202136 sc-202136A | 5 g 25 g | $41.00 $128.00 | 4 | |
NSAID affecting CYP2C54 directly by inhibiting arachidonic acid metabolic processes. Modifies endoplasmic reticulum and membrane dynamics, impairing the enzyme's participation in these pathways. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
Antifungal agent acting as a direct inhibitor of CYP2C54 by interfering with linoleic acid metabolic processes. Disrupts membrane-bounded organelle functions, hindering the enzyme's predicted location. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Lipid-lowering agent in research indirectly inhibiting CYP2C54 by affecting linoleic acid metabolic processes. Alters intracellular membrane dynamics, impacting the enzyme's predicted activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker indirectly inhibiting CYP2C54 by modulating intracellular calcium levels. Disrupts cytoplasmic and intracellular membrane functions, influencing the enzyme's predicted activity. | ||||||
Terbinafine | 91161-71-6 | sc-338609 | 100 mg | $560.00 | 1 | |
Antifungal agent in research acting as a direct inhibitor of CYP2C54 by interfering with linoleic acid metabolic processes. Alters endoplasmic reticulum dynamics, hindering the enzyme's predicted participation. | ||||||